Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism Bacterial toxin inhibitors, T3SS inhibitors(Type III secretion system protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pseudomonas aeruginosa infection | Preclinical | BE | 23 Mar 2017 | |
Pseudomonas Infections | Discovery | SE | 01 Oct 2011 |